ArticleMedComm2025

Platelet-to-Neutrophil Ratio: A Novel Prognostic Indicator for Anti-PD-1-Based Therapy in Relapsed/Refractory Hodgkin Lymphoma and Solid Tumors.

Yuting Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.